| Literature DB >> 36152187 |
Jara Bouma1, Marjolein Soethoudt1,2, Noortje van Gils1, Lizi Xia1, Mario van der Stelt2,3, Laura H Heitman4,5.
Abstract
Cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) are G protein-coupled receptors (GPCRs) that activate a variety of pathways upon activation by (partial) agonists including the G protein pathway and the recruitment of β-arrestins. Differences in the activation level of these pathways lead to biased signaling. Here, we describe a detailed protocol to characterize the potency and efficacy of ligands to induce or inhibit β-arrestin recruitment to the human CB1R and CB2R using the PathHunter® assay. This is a cellular assay that uses a β-galactosidase complementation system which has a chemiluminescent read-out and can be performed in 384-well plates. We have successfully used this assay to characterize a set of reference ligands (both agonists, antagonists, and an inverse agonist) on human CB1R and CB2R, of which some examples will be presented here.Entities:
Keywords: Biased signaling; Cannabinoid receptors; Desensitization; DiscoverX PathHunter®; Functional selectivity; GPCRs; Internalization; Receptor signaling; β-arrestin
Mesh:
Substances:
Year: 2023 PMID: 36152187 DOI: 10.1007/978-1-0716-2728-0_15
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745